Substrate Cleavage Analysis of Furin and Related Proprotein Convertases

We present the data and the technology, a combination of which allows us to determine the identity of proprotein convertases (PCs) related to the processing of specific protein targets including viral and bacterial pathogens. Our results, which support and extend the data of other laboratories, are required for the design of effective inhibitors of PCs because, in general, an inhibitor design starts with a specific substrate. Seven proteinases of the human PC family cleave the multibasic motifs R-X-(R/K/X)-R↓ and, as a result, transform proproteins, including those from pathogens, into biologically active proteins and peptides. The precise cleavage preferences of PCs have not been known in sufficient detail; hence we were unable to determine the relative importance of the individual PCs in infectious diseases, thus making the design of specific inhibitors exceedingly difficult. To determine the cleavage preferences of PCs in more detail, we evaluated the relative efficiency of furin, PC2, PC4, PC5/6, PC7, and PACE4 in cleaving over 100 decapeptide sequences representing the R-X-(R/K/X)-R↓ motifs of human, bacterial, and viral proteins. Our computer analysis of the data and the follow-on cleavage analysis of the selected full-length proteins corroborated our initial results thus allowing us to determine the cleavage preferences of the PCs and to suggest which PCs are promising drug targets in infectious diseases. Our results also suggest that pathogens, including anthrax PA83 and the avian influenza A H5N1 (bird flu) hemagglutinin precursor, evolved to be as sensitive to PC proteolysis as the most sensitive normal human proteins.

[1]  N. Seidah,et al.  Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides , 2001 .

[2]  N. Seidah,et al.  The family of pro-hormone and pro-protein convertases. , 1993, Biochemical Society transactions.

[3]  A. Prat,et al.  The activation and physiological functions of the proprotein convertases. , 2008, The international journal of biochemistry & cell biology.

[4]  Michal Lebl,et al.  Search for optimal coupling reagent in multiple peptide synthesizer. , 2006, Biopolymers.

[5]  H. Feldmann,et al.  The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. , 1999, Archives of virology. Supplementum.

[6]  W. V. D. Van de Ven,et al.  Curbing activation: proprotein convertases in homeostasis and pathology , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Stephen J. Weiss,et al.  Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.

[8]  D. King,et al.  A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.

[9]  S. Millis,et al.  Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine , 2006, Proceedings of the National Academy of Sciences.

[10]  M. Lebl,et al.  Alternative to piperidine in Fmoc solid-phase synthesis. , 2006, Journal of combinatorial chemistry.

[11]  H. Klenk,et al.  Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. , 1994, Biochimie.

[12]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[13]  S. Leppla,et al.  Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases , 1994, Infection and immunity.

[14]  M. Chiron,et al.  Furin-mediated Cleavage of Pseudomonas Exotoxin-derived Chimeric Toxins* , 1997, The Journal of Biological Chemistry.

[15]  E. Decroly,et al.  Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. , 2000, Biochimica et biophysica acta.

[16]  D. Bassi,et al.  Proprotein convertases: “Master switches” in the regulation of tumor growth and progression , 2005, Molecular carcinogenesis.

[17]  K. Gensberg,et al.  Subtilisin-related serine proteases in the mammalian constitutive secretory pathway. , 1998, Seminars in cell & developmental biology.

[18]  E. Fleck,et al.  Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels , 2005, Journal of Molecular Medicine.

[19]  Xiaorong Zhu,et al.  Furin and prohormone convertase 1/3 are major convertases in the processing of mouse pro-growth hormone-releasing hormone. , 2004, Endocrinology.

[20]  K Nakayama,et al.  Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. , 1997, The Biochemical journal.

[21]  H. Klenk,et al.  Influenza viruses, cell enzymes, and pathogenicity. , 1995, American journal of respiratory and critical care medicine.

[22]  Monika Milewski,et al.  Decoding randomly ordered DNA arrays. , 2004, Genome research.

[23]  J. Hutton,et al.  Molecular and cellular regulation of prohormone processing. , 1998, Seminars in cell & developmental biology.

[24]  N. Seidah,et al.  Proprotein Convertases , 2011, Methods in Molecular Biology.

[25]  W. Malmquist,et al.  Soluble antigen of bovine viral diarrhea virus , 1965, Archiv für die gesamte Virusforschung.

[26]  N. Seidah,et al.  Proprotein convertases: lessons from knockouts , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Y. Patel,et al.  Processing and intracellular targeting of prosomatostatin-derived peptides: the role of mammalian endoproteases. , 1995, Ciba Foundation symposium.

[28]  M. Zambon,et al.  The pathogenesis of influenza in humans , 2001, Reviews in medical virology.

[29]  Jeffrey W. Smith,et al.  Targeting Host Cell Furin Proprotein Convertases as a Therapeutic Strategy against Bacterial Toxins and Viral Pathogens* , 2007, Journal of Biological Chemistry.

[30]  Jeffrey W. Smith,et al.  Proteolysis of the Membrane Type-1 Matrix Metalloproteinase Prodomain , 2007, Journal of Biological Chemistry.

[31]  F. Heinz,et al.  Proteolytic activation of tick-borne encephalitis virus by furin , 1997, Journal of virology.

[32]  David J Stevens,et al.  Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation , 1998, Cell.

[33]  T. Komiyama,et al.  Precursor processing by kex2/furin proteases. , 2002, Chemical reviews.

[34]  N. Seidah,et al.  In Vitro Characterization of the Novel Proprotein Convertase PC7* , 1997, The Journal of Biological Chemistry.

[35]  Jeffrey W. Smith,et al.  Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses. , 2007, Biochemical Journal.

[36]  R. Mains,et al.  Peptide biosynthetic processing: distinguishing prohormone convertases PC1 and PC2 , 1996, Molecular and Cellular Endocrinology.

[37]  I. Lindberg,et al.  The Furin Inhibitor Hexa-d-Arginine Blocks the Activation of Pseudomonas aeruginosa Exotoxin A In Vivo , 2002, Infection and Immunity.

[38]  R. Leduc,et al.  Inhibitory Potency and Specificity of Subtilase-like Pro-protein Convertase (SPC) Prodomains* , 2002, The Journal of Biological Chemistry.

[39]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[40]  Comparative characterization of two forms of recombinant human SPC1 secreted from Schneider 2 cells. , 2000, Protein expression and purification.

[41]  T. Rungrotmongkol,et al.  Source of high pathogenicity of an avian influenza virus H5N1: why H5 is better cleaved by furin. , 2008, Biophysical journal.

[42]  T. D. Schneider,et al.  Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.

[43]  Jeffrey W. Smith,et al.  Switching the Substrate Specificity of the Two-Component NS2B-NS3 Flavivirus Proteinase by Structure-Based Mutagenesis , 2007, Journal of Virology.

[44]  I. Lindberg,et al.  Cleavage of recombinant proenkephalin and blockade mutants by prohormone convertases 1 and 2: an in vitro specificity study , 2003, Journal of neurochemistry.

[45]  M. Lebl.  New technique for high-throughput synthesis. , 1999, Bioorganic & medicinal chemistry letters.

[46]  M. Beinfeld.  Prohormone and proneuropeptide processing , 1998, Endocrine.

[47]  Ping Wang,et al.  Proprotein Convertase Furin Interacts with and Cleaves Pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi Network* , 2004, Journal of Biological Chemistry.

[48]  M. Lebl,et al.  A method for rapid protease substrate evaluation and optimization. , 2006, Combinatorial chemistry & high throughput screening.

[49]  Neil D. Rawlings,et al.  Handbook of proteolytic enzymes , 1998 .

[50]  N. Seidah,et al.  Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160 , 1997, FEBS letters.

[51]  N. Seidah,et al.  Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7. , 2000, The Biochemical journal.